Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model

被引:81
作者
Pawlinski, R
Pedersen, B
Kehrle, B
Aird, WC
Frank, RD
Guha, M
Mackman, N
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Beth Israel Deaconess Med Ctr, Mol Med Unit, Boston, MA 02215 USA
关键词
D O I
10.1182/blood-2002-07-2303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In septic shock, tissue factor (TF) activates blood coagulation, and cytokines and chemokines orchestrate an inflammatory response. In this study, the role of Egr-1 in lipopolysaccharide (LPS) induction of TF and inflammatory mediators in vivo was evaluated using Egr-1(+/+) and Egr-1(-/-) mice. Ad. ministration of LPS transiently increased the steady-state levels of Egr-1 mRNA in the kidneys and lungs of Egr-1(+/+) mice with maximal induction at one hour. Egr-1 was expressed in epithelial cells in the kidneys and lungs in untreated and LPS-treated mice. LPS induction of monocyte chemoattractant protein mRNA in the kidneys and lungs of Egr-1(-/-) mice was not affected at 3 hours, but its expression was significantly reduced at 8 hours compared with the expression observed in Egr-1(+/+) mice. Similarly, LIPS Induction of TF mRNA expression in the kidneys and lungs at 8 hours was reduced 16 Egr-1 mice. However, Egr-1 deficiency did not affect plasma levels of tumor necrosis factor a. in endotoxemic mice. Moreover, Egr-1(+/+) and Egr-1(-/-) mice exhibited similar survival times in a model of acute endotoxemia. these data indicate that Egr-1 does not contribute to the early inflammatory response in the kidneys and lungs or the early systemic inflammatory response in endotoxemic mice. However, Egr-1 does contribute to the sustained expression of Inflammatory mediators and to the maximal expression of TF at 8 hours in the kidneys and lungs. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3940 / 3947
页数:8
相关论文
共 51 条
[1]   Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis - Question and answer session after scientific review [J].
Vincent, JL ;
Abraham, E ;
Esmon, C ;
Hack, CE .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S33-S33
[2]   Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFκB and AP-1 in vivo [J].
Bozinovski, S ;
Jones, JE ;
Vlahos, R ;
Hamilton, JA ;
Anderson, GP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (45) :42808-42814
[3]   GENERATION IN PLASMA OF A FAST-ACTING INHIBITOR OF PLASMINOGEN-ACTIVATOR IN RESPONSE TO ENDOTOXIN STIMULATION [J].
COLUCCI, M ;
PARAMO, JA ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (03) :818-824
[4]  
Dackiw APB, 1996, ARCH SURG-CHICAGO, V131, P1273
[5]  
DRAKE TA, 1993, AM J PATHOL, V142, P1458
[6]  
DRAKE TA, 1989, AM J PATHOL, V134, P1087
[7]  
DUSTIN ML, 1986, J IMMUNOL, V137, P245
[8]   Lipopolysaccharide induction of tissue factor expression in rabbits [J].
Erlich, J ;
Fearns, C ;
Mathison, J ;
Ulevitch, RJ ;
Mackman, N .
INFECTION AND IMMUNITY, 1999, 67 (05) :2540-2546
[9]  
Essani NA, 1996, J IMMUNOL, V156, P2956
[10]   MURINE CD14 GENE-EXPRESSION IN-VIVO - EXTRAMYELOID SYNTHESIS AND REGULATION BY LIPOPOLYSACCHARIDE [J].
FEARNS, C ;
KRAVCHENKO, VV ;
ULEVITCH, RJ ;
LOSKUTOFF, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :857-866